Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
Asıl Yazarlar: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
BioMed Central
2016
|
Benzer Materyaller
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
Yazar:: Saunders, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Older patients are eligible for trial of lithium and valproate.
Yazar:: Rendell, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
New trial should clarify lithium use in bipolar disorder.
Yazar:: Geddes, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Lith6
Yazar:: Malcolm A. Lyons, ve diğerleri
Baskı/Yayın Bilgisi: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
Yazar:: Atkinson, L, ve diğerleri
Baskı/Yayın Bilgisi: (2019)